 | • レポートコード：MRC2312MG10483 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の体外診断用医薬品原料市場規模と予測を収録しています。・世界の体外診断用医薬品原料市場：売上、2018年-2023年、2024年-2029年 ・世界の体外診断用医薬品原料市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の体外診断用医薬品原料市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗原」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 体外診断用医薬品原料のグローバル主要企業は、HyTest、 BBI Solution、 Meridian Bioscience、 Fapon Biotech、 BiosPacific、 Cusabio、 Aalto Bio、 Life Technologies、 Zoonbio Biotechnology、 OYC Europe、 PRAHAS Healthcare、 Microbix Biosystems、 VirionSerion GmbH、 Roche、 Autobio Diagnostics、 Sekisui Diagnosticなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、体外診断用医薬品原料のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の体外診断用医薬品原料市場：タイプ別、2018年-2023年、2024年-2029年 世界の体外診断用医薬品原料市場：タイプ別市場シェア、2022年 ・抗原、抗体、診断用酵素、その他 世界の体外診断用医薬品原料市場：用途別、2018年-2023年、2024年-2029年 世界の体外診断用医薬品原料市場：用途別市場シェア、2022年 ・分子診断、免疫診断、生化学診断、新薬研究開発 世界の体外診断用医薬品原料市場：地域・国別、2018年-2023年、2024年-2029年 世界の体外診断用医薬品原料市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における体外診断用医薬品原料のグローバル売上、2018年-2023年 ・主要企業における体外診断用医薬品原料のグローバル売上シェア、2022年 ・主要企業における体外診断用医薬品原料のグローバル販売量、2018年-2023年 ・主要企業における体外診断用医薬品原料のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 HyTest、 BBI Solution、 Meridian Bioscience、 Fapon Biotech、 BiosPacific、 Cusabio、 Aalto Bio、 Life Technologies、 Zoonbio Biotechnology、 OYC Europe、 PRAHAS Healthcare、 Microbix Biosystems、 VirionSerion GmbH、 Roche、 Autobio Diagnostics、 Sekisui Diagnostic ************************************************************* ・調査・分析レポートの概要 体外診断用医薬品原料市場の定義 市場セグメント 世界の体外診断用医薬品原料市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の体外診断用医薬品原料市場規模 世界の体外診断用医薬品原料市場規模：2022年 VS 2029年 世界の体外診断用医薬品原料市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの体外診断用医薬品原料の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の体外診断用医薬品原料製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：抗原、抗体、診断用酵素、その他 体外診断用医薬品原料のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：分子診断、免疫診断、生化学診断、新薬研究開発 体外診断用医薬品原料の用途別グローバル売上・予測 ・地域別市場分析 地域別体外診断用医薬品原料市場規模 2022年と2029年 地域別体外診断用医薬品原料売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） HyTest、 BBI Solution、 Meridian Bioscience、 Fapon Biotech、 BiosPacific、 Cusabio、 Aalto Bio、 Life Technologies、 Zoonbio Biotechnology、 OYC Europe、 PRAHAS Healthcare、 Microbix Biosystems、 VirionSerion GmbH、 Roche、 Autobio Diagnostics、 Sekisui Diagnostic ... |
This research report provides a comprehensive analysis of the IVD (In Vitro Diagnostic) Raw Materials market, focusing on the current trends, market dynamics, and future prospects. The report explores the global IVD (In Vitro Diagnostic) Raw Materials market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of IVD (In Vitro Diagnostic) Raw Materials, challenges faced by the industry, and potential opportunities for market players.
The global IVD (In Vitro Diagnostic) Raw Materials market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The IVD (In Vitro Diagnostic) Raw Materials market presents opportunities for various stakeholders, including Molecular Diagnostics, Immunodiagnostic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in IVD (In Vitro Diagnostic) Raw Materials market. Additionally, the growing consumer demand present avenues for market expansion.
The global IVD (In Vitro Diagnostic) Raw Materials market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
With the continuous development of in vitro diagnostic technology, IVD raw materials are also continuously improved and improved. The following are the development trends of IVD raw materials:
New labeling reagents: With the development of nanotechnology, new labeling reagents such as nanoparticle labeling reagents, quantum dot labeling reagents, etc. are gradually used in the field of in vitro diagnostics. Their advantages include high sensitivity, good stability, and multiple labeling.
Microfluidic technology: Microfluidic technology is a method of migrating the sample analysis process into tiny flow channels, which can achieve high-throughput, fast, and automated diagnostic testing. Microfluidic technology can also reduce the consumption of samples and reagents, saving costs.
Genetic testing: With the deepening understanding of gene variation, the application of genetic testing in in vitro diagnosis is becoming more and more extensive. The development of next-generation sequencing technology makes genetic testing faster and more accurate, and can detect multiple genes at the same time, providing better means for personalized diagnosis and treatment.
Biomolecular markers: Biomolecular markers are an important basis for disease prevention, diagnosis, and treatment. Therefore, the identification and detection technology of biomolecular markers has attracted more and more attention. In the future, with the continuous development of biotechnology, more biomolecular markers will be discovered and applied in clinical diagnosis.
Personalized Medicine: As medical technology continues to evolve, so does the need for personalized medicine. Personalized medicine depends on accurate diagnosis and treatment methods, so the demand for in vitro diagnostic reagents will continue to increase.
To sum up, with the continuous development of science and technology, IVD raw materials will continue to improve and improve, providing better support for the development of the field of in vitro diagnostics.
Key Features:
The research report on the IVD (In Vitro Diagnostic) Raw Materials market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the IVD (In Vitro Diagnostic) Raw Materials market.
Market Overview: The report provides a comprehensive overview of the IVD (In Vitro Diagnostic) Raw Materials market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Antigen, Antibody), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the IVD (In Vitro Diagnostic) Raw Materials market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the IVD (In Vitro Diagnostic) Raw Materials market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the IVD (In Vitro Diagnostic) Raw Materials market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the IVD (In Vitro Diagnostic) Raw Materials market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the IVD (In Vitro Diagnostic) Raw Materials market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the IVD (In Vitro Diagnostic) Raw Materials market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for IVD (In Vitro Diagnostic) Raw Materials, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the IVD (In Vitro Diagnostic) Raw Materials market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
IVD (In Vitro Diagnostic) Raw Materials market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Antigen
Antibody
Diagnostic Enzymes
Others
Market segment by Application
Molecular Diagnostics
Immunodiagnostic
Biochemical Diagnostics
New Drug R&D
Global IVD (In Vitro Diagnostic) Raw Materials Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
HyTest
BBI Solution
Meridian Bioscience
Fapon Biotech
BiosPacific
Cusabio
Aalto Bio
Life Technologies
Zoonbio Biotechnology
OYC Europe
PRAHAS Healthcare
Microbix Biosystems
VirionSerion GmbH
Roche
Autobio Diagnostics
Sekisui Diagnostic
Outline of Major Chapters:
Chapter 1: Introduces the definition of IVD (In Vitro Diagnostic) Raw Materials, market overview.
Chapter 2: Global IVD (In Vitro Diagnostic) Raw Materials market size in revenue.
Chapter 3: Detailed analysis of IVD (In Vitro Diagnostic) Raw Materials company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of IVD (In Vitro Diagnostic) Raw Materials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 IVD (In Vitro Diagnostic) Raw Materials Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global IVD (In Vitro Diagnostic) Raw Materials Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global IVD (In Vitro Diagnostic) Raw Materials Overall Market Size
2.1 Global IVD (In Vitro Diagnostic) Raw Materials Market Size: 2022 VS 2029
2.2 Global IVD (In Vitro Diagnostic) Raw Materials Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top IVD (In Vitro Diagnostic) Raw Materials Players in Global Market
3.2 Top Global IVD (In Vitro Diagnostic) Raw Materials Companies Ranked by Revenue
3.3 Global IVD (In Vitro Diagnostic) Raw Materials Revenue by Companies
3.4 Top 3 and Top 5 IVD (In Vitro Diagnostic) Raw Materials Companies in Global Market, by Revenue in 2022
3.5 Global Companies IVD (In Vitro Diagnostic) Raw Materials Product Type
3.6 Tier 1, Tier 2 and Tier 3 IVD (In Vitro Diagnostic) Raw Materials Players in Global Market
3.6.1 List of Global Tier 1 IVD (In Vitro Diagnostic) Raw Materials Companies
3.6.2 List of Global Tier 2 and Tier 3 IVD (In Vitro Diagnostic) Raw Materials Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global IVD (In Vitro Diagnostic) Raw Materials Market Size Markets, 2022 & 2029
4.1.2 Antigen
4.1.3 Antibody
4.1.4 Diagnostic Enzymes
4.1.5 Others
4.2 By Type – Global IVD (In Vitro Diagnostic) Raw Materials Revenue & Forecasts
4.2.1 By Type – Global IVD (In Vitro Diagnostic) Raw Materials Revenue, 2018-2023
4.2.2 By Type – Global IVD (In Vitro Diagnostic) Raw Materials Revenue, 2024-2029
4.2.3 By Type – Global IVD (In Vitro Diagnostic) Raw Materials Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global IVD (In Vitro Diagnostic) Raw Materials Market Size, 2022 & 2029
5.1.2 Molecular Diagnostics
5.1.3 Immunodiagnostic
5.1.4 Biochemical Diagnostics
5.1.5 New Drug R&D
5.2 By Application – Global IVD (In Vitro Diagnostic) Raw Materials Revenue & Forecasts
5.2.1 By Application – Global IVD (In Vitro Diagnostic) Raw Materials Revenue, 2018-2023
5.2.2 By Application – Global IVD (In Vitro Diagnostic) Raw Materials Revenue, 2024-2029
5.2.3 By Application – Global IVD (In Vitro Diagnostic) Raw Materials Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global IVD (In Vitro Diagnostic) Raw Materials Market Size, 2022 & 2029
6.2 By Region – Global IVD (In Vitro Diagnostic) Raw Materials Revenue & Forecasts
6.2.1 By Region – Global IVD (In Vitro Diagnostic) Raw Materials Revenue, 2018-2023
6.2.2 By Region – Global IVD (In Vitro Diagnostic) Raw Materials Revenue, 2024-2029
6.2.3 By Region – Global IVD (In Vitro Diagnostic) Raw Materials Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America IVD (In Vitro Diagnostic) Raw Materials Revenue, 2018-2029
6.3.2 US IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.3.3 Canada IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.3.4 Mexico IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe IVD (In Vitro Diagnostic) Raw Materials Revenue, 2018-2029
6.4.2 Germany IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.4.3 France IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.4.4 U.K. IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.4.5 Italy IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.4.6 Russia IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.4.7 Nordic Countries IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.4.8 Benelux IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia IVD (In Vitro Diagnostic) Raw Materials Revenue, 2018-2029
6.5.2 China IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.5.3 Japan IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.5.4 South Korea IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.5.5 Southeast Asia IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.5.6 India IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America IVD (In Vitro Diagnostic) Raw Materials Revenue, 2018-2029
6.6.2 Brazil IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.6.3 Argentina IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa IVD (In Vitro Diagnostic) Raw Materials Revenue, 2018-2029
6.7.2 Turkey IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.7.3 Israel IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.7.4 Saudi Arabia IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
6.7.5 UAE IVD (In Vitro Diagnostic) Raw Materials Market Size, 2018-2029
7 IVD (In Vitro Diagnostic) Raw Materials Companies Profiles
7.1 HyTest
7.1.1 HyTest Company Summary
7.1.2 HyTest Business Overview
7.1.3 HyTest IVD (In Vitro Diagnostic) Raw Materials Major Product Offerings
7.1.4 HyTest IVD (In Vitro Diagnostic) Raw Materials Revenue in Global Market (2018-2023)
7.1.5 HyTest Key News & Latest Developments
7.2 BBI Solution
7.2.1 BBI Solution Company Summary
7.2.2 BBI Solution Business Overview
7.2.3 BBI Solution IVD (In Vitro Diagnostic) Raw Materials Major Product Offerings
7.2.4 BBI Solution IVD (In Vitro Diagnostic) Raw Materials Revenue in Global Market (2018-2023)
7.2.5 BBI Solution Key News & Latest Developments
7.3 Meridian Bioscience
7.3.1 Meridian Bioscience Company Summary
7.3.2 Meridian Bioscience Business Overview
7.3.3 Meridian Bioscience IVD (In Vitro Diagnostic) Raw Materials Major Product Offerings
7.3.4 Meridian Bioscience IVD (In Vitro Diagnostic) Raw Materials Revenue in Global Market (2018-2023)
7.3.5 Meridian Bioscience Key News & Latest Developments
7.4 Fapon Biotech
7.4.1 Fapon Biotech Company Summary
7.4.2 Fapon Biotech Business Overview
7.4.3 Fapon Biotech IVD (In Vitro Diagnostic) Raw Materials Major Product Offerings
7.4.4 Fapon Biotech IVD (In Vitro Diagnostic) Raw Materials Revenue in Global Market (2018-2023)
7.4.5 Fapon Biotech Key News & Latest Developments
7.5 BiosPacific
7.5.1 BiosPacific Company Summary
7.5.2 BiosPacific Business Overview
7.5.3 BiosPacific IVD (In Vitro Diagnostic) Raw Materials Major Product Offerings
7.5.4 BiosPacific IVD (In Vitro Diagnostic) Raw Materials Revenue in Global Market (2018-2023)
7.5.5 BiosPacific Key News & Latest Developments
7.6 Cusabio
7.6.1 Cusabio Company Summary
7.6.2 Cusabio Business Overview
7.6.3 Cusabio IVD (In Vitro Diagnostic) Raw Materials Major Product Offerings
7.6.4 Cusabio IVD (In Vitro Diagnostic) Raw Materials Revenue in Global Market (2018-2023)
7.6.5 Cusabio Key News & Latest Developments
7.7 Aalto Bio
7.7.1 Aalto Bio Company Summary
7.7.2 Aalto Bio Business Overview
7.7.3 Aalto Bio IVD (In Vitro Diagnostic) Raw Materials Major Product Offerings
7.7.4 Aalto Bio IVD (In Vitro Diagnostic) Raw Materials Revenue in Global Market (2018-2023)
7.7.5 Aalto Bio Key News & Latest Developments
7.8 Life Technologies
7.8.1 Life Technologies Company Summary
7.8.2 Life Technologies Business Overview
7.8.3 Life Technologies IVD (In Vitro Diagnostic) Raw Materials Major Product Offerings
7.8.4 Life Technologies IVD (In Vitro Diagnostic) Raw Materials Revenue in Global Market (2018-2023)
7.8.5 Life Technologies Key News & Latest Developments
7.9 Zoonbio Biotechnology
7.9.1 Zoonbio Biotechnology Company Summary
7.9.2 Zoonbio Biotechnology Business Overview
7.9.3 Zoonbio Biotechnology IVD (In Vitro Diagnostic) Raw Materials Major Product Offerings
7.9.4 Zoonbio Biotechnology IVD (In Vitro Diagnostic) Raw Materials Revenue in Global Market (2018-2023)
7.9.5 Zoonbio Biotechnology Key News & Latest Developments
7.10 OYC Europe
7.10.1 OYC Europe Company Summary
7.10.2 OYC Europe Business Overview
7.10.3 OYC Europe IVD (In Vitro Diagnostic) Raw Materials Major Product Offerings
7.10.4 OYC Europe IVD (In Vitro Diagnostic) Raw Materials Revenue in Global Market (2018-2023)
7.10.5 OYC Europe Key News & Latest Developments
7.11 PRAHAS Healthcare
7.11.1 PRAHAS Healthcare Company Summary
7.11.2 PRAHAS Healthcare Business Overview
7.11.3 PRAHAS Healthcare IVD (In Vitro Diagnostic) Raw Materials Major Product Offerings
7.11.4 PRAHAS Healthcare IVD (In Vitro Diagnostic) Raw Materials Revenue in Global Market (2018-2023)
7.11.5 PRAHAS Healthcare Key News & Latest Developments
7.12 Microbix Biosystems
7.12.1 Microbix Biosystems Company Summary
7.12.2 Microbix Biosystems Business Overview
7.12.3 Microbix Biosystems IVD (In Vitro Diagnostic) Raw Materials Major Product Offerings
7.12.4 Microbix Biosystems IVD (In Vitro Diagnostic) Raw Materials Revenue in Global Market (2018-2023)
7.12.5 Microbix Biosystems Key News & Latest Developments
7.13 VirionSerion GmbH
7.13.1 VirionSerion GmbH Company Summary
7.13.2 VirionSerion GmbH Business Overview
7.13.3 VirionSerion GmbH IVD (In Vitro Diagnostic) Raw Materials Major Product Offerings
7.13.4 VirionSerion GmbH IVD (In Vitro Diagnostic) Raw Materials Revenue in Global Market (2018-2023)
7.13.5 VirionSerion GmbH Key News & Latest Developments
7.14 Roche
7.14.1 Roche Company Summary
7.14.2 Roche Business Overview
7.14.3 Roche IVD (In Vitro Diagnostic) Raw Materials Major Product Offerings
7.14.4 Roche IVD (In Vitro Diagnostic) Raw Materials Revenue in Global Market (2018-2023)
7.14.5 Roche Key News & Latest Developments
7.15 Autobio Diagnostics
7.15.1 Autobio Diagnostics Company Summary
7.15.2 Autobio Diagnostics Business Overview
7.15.3 Autobio Diagnostics IVD (In Vitro Diagnostic) Raw Materials Major Product Offerings
7.15.4 Autobio Diagnostics IVD (In Vitro Diagnostic) Raw Materials Revenue in Global Market (2018-2023)
7.15.5 Autobio Diagnostics Key News & Latest Developments
7.16 Sekisui Diagnostic
7.16.1 Sekisui Diagnostic Company Summary
7.16.2 Sekisui Diagnostic Business Overview
7.16.3 Sekisui Diagnostic IVD (In Vitro Diagnostic) Raw Materials Major Product Offerings
7.16.4 Sekisui Diagnostic IVD (In Vitro Diagnostic) Raw Materials Revenue in Global Market (2018-2023)
7.16.5 Sekisui Diagnostic Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer